Showing results (831-840 of 1,043) with videos related to
Sort By:
Pageof 105
Neuroendocrinology|September 10, 2020
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom IndexSara Shaunfield, Kimberly A Webster, Karen Kaiser, et al.Applied Clinical Informatics|December 28, 2023
Seamless Integration of Computer-Adaptive Patient Reported Outcomes into an Electronic Health RecordKyle Nolla, Luke V Rasmussen, Nan E Rothrock, et al.Journal of Palliative Medicine|April 18, 2013
Preliminary results of the generation of a shortened quality-of-life assessment for patients with advanced cancer: the FACIT-Pal-14Liang Zeng, Gillian Bedard, David Cella, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2023
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical TrialsBellinda L King-Kallimanis, Melanie Calvert, David Cella, et al.Blood|July 1, 2009
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, et al.Journal of Neurology|June 14, 2019
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life PlanningNoelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.Contemporary Clinical Trials|March 29, 2023
Implementation and evaluation of an expanded electronic health record-integrated bilingual electronic symptom management program across a multi-site Comprehensive Cancer Center: The NU IMPACT protocolDavid Cella, Sofia F Garcia, September Cahue, et al.BMC Cardiovascular Disorders|April 22, 2021
Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonaceptDavid Lin, Allan Klein, David Cella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology GroupAmye J Tevaarwerk, Molin Wang, Fengmin Zhao, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2017
Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measuresJin-Shei Lai, Siera Goodnight, Nancy R Downing, et al.Pageof 105